The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Abstract
BACKGROUND: The prevalence of patent foramen ovale among patients with cryptogenic stroke is higher than that in the general population. Closure with a percutaneous device is often recommended in such patients, but it is not known whether this intervention reduces the risk of recurrent stroke. METHODS: We conducted a multicenter, randomized, open-label trial of closure with a percutaneous device, as compared with medical therapy alone, in patients between 18 and 60 years of age who presented with a cryptogenic stroke or transient ischemic attack (TIA) and had a patent foramen ovale. The primary end point was a composite of stroke or transient ischemic attack during 2 years of follow-up, death from any cause during the first 30 days, or death from neurologic causes between 31 days and 2 years. RESULTS: A total of 909 patients were enrolled in the trial. The cumulative incidence (Kaplan-Meier estimate) of the primary end point was 5.5% in the closure group (447 patients) as compared with 6.8% in the medical-therapy group (462 patients) (adjusted hazard ratio, 0.78; 95% confidence interval, 0.45 to 1.35; P=0.37). The respective rates were 2.9% and 3.1% for stroke (P=0.79) and 3.1% and 4.1% for TIA (P=0.44). No deaths occurred by 30 days in either group, and there were no deaths from neurologic causes during the 2-year follow-up period. A cause other than paradoxical embolism was usually apparent in patients with recurrent neurologic events. CONCLUSIONS: In patients with cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device did not offer a greater benefit than medical therapy alone for the prevention of recurrent stroke or TIA. (Funded by NMT Medical; ClinicalTrials.gov number, NCT00201461.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hagen, P. T., SCHOLZ, D. G., & Edwards, W. D. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60336-x · Cited by 2,528
Easton, J. D., Saver, J. L., Albers, G. W., Alberts, M. J., Chaturvedi, S., Feldmann, E., Hatsukami, T. S., Higashida, R. T., Johnston, S. C., Kidwell, C. S., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192218 · Cited by 1,845
Self-citationMas, J.-L., Arquizan, C., Lamy, C., Zuber, M., Cabanes, L., Derumeaux, G., & Coste, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011503 · Cited by 1,361
Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000017498.88393.44 · Cited by 949
Transient Ischemic Attack — Proposal for a New Definition
Albers, G. W., Caplan, L. R., Easton, J. D., Fayad, P. B., Mohr, J. P., Saver, J. L., & Sherman, D. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmsb020987 · Cited by 840
Self-citationPATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS
Webster, M. W. I., Smith, H. J., Sharpe, D. N., Chancellor, A. M., Swift, D. L., Bass, N. M., & Glasgow, G. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92944-3 · Cited by 823
Infarcts of undetermined cause: The NINCDS stroke data bank
Sacco, R. L., Ellenberg, J. H., Mohr, J. P., Tatemichi, T. K., Hier, D. B., Price, T. R., & Wolf, P. A. (1989) · Annals of Neurology · doi:10.1002/ana.410250410 · Cited by 767
Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke
Di Tullio, M., Sacco, R. L., Gopal, A., Mohr, J. P., & Homma, S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-461 · Cited by 600
Cabanes, L., Mas, J. L., Cohen, A., Amarenco, P., Cabanes, P. A., Oubary, P., Chedru, F., Guérin, F., Bousser, M. G., & de Recondo, J. (1993) · Stroke · doi:10.1161/01.str.24.12.1865 · Cited by 572
Lamy, C., Giannesini, C., Zuber, M., Arquizan, C., Meder, J. F., Trystram, D., Coste, J., & Mas, J. L. (2002) · Stroke · doi:10.1161/hs0302.104543 · Cited by 509
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Embolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Mas, J.-L., Derumeaux, G., Guillon, B., Massardier, E., Hosseini, H., Mechtouff, L., Arquizan, C., Béjot, Y., Vuillier, F., Detante, O., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705915 · Cited by 1,183
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Søndergaard, L., Kasner, S. E., Rhodes, J. F., Andersen, G., Iversen, H. K., Nielsen-Kudsk, J. E., Settergren, M., Sjöstrand, C., Roine, R. O., Hildick-Smith, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707404 · Cited by 1,137
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
Saver, J. L., Carroll, J. D., Thaler, D. E., Smalling, R. W., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610057 · Cited by 1,127
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
Carroll, J. D., Saver, J. L., Thaler, D. E., Smalling, R. W., Berry, S., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301440 · Cited by 983
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Meier, B., Kalesan, B., Mattle, H. P., Khattab, A. A., Hildick-Smith, D., Dudek, D., Andersen, G., Ibrahim, R., Schuler, G., Walton, A. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211716 · Cited by 920
Feske, S. K. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.07.027 · Cited by 822
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke
Kent, D. M., Ruthazer, R., Weimar, C., Mas, J.-L., Serena, J., Homma, S., Di Angelantonio, E., Di Tullio, M. R., Lutz, J. S., Elkind, M. S. V., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a08d59 · Cited by 637
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Lee, P. H., Song, J.-K., Kim, J. S., Heo, R., Lee, S., Kim, D.-H., Song, J.-M., Kang, D.-H., Kwon, S. U., Kang, D.-W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.046 · Cited by 588
Giglia, T. M., Massicotte, M. P., Tweddell, J. S., Barst, R. J., Bauman, M., Erickson, C. C., Feltes, T. F., Foster, E., Hinoki, K., Ichord, R. N., et al. (2013) · Circulation · doi:10.1161/01.cir.0000436140.77832.7a · Cited by 390
Hankey, G. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70255-2 · Cited by 384
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
Diener, H.-C., & Hankey, G. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.072 · Cited by 364
Recognition and management of stroke in young adults and adolescents
Singhal, A. B., Biller, J., Elkind, M. S., Fullerton, H. J., Jauch, E. C., Kittner, S. J., Levine, D. A., & Levine, S. R. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a4a451 · Cited by 277
Saver, J. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503946 · Cited by 276
Leptin receptor action and mechanisms of leptin resistance
Münzberg, H., Björnholm, M., Bates, S. H., & Myers, M. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4432-1 · Cited by 261
Metadata
- Authors
- Furlan, A. J., Reisman, M., Massaro, J., Mauri, L., Adams, H., Albers, G. W., Felberg, R., Herrmann, H., Kar, S., Landzberg, M., Raizner, A., & Wechsler, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-03-15
- Volume
- 366
- Issue
- 11
- Pages
- 991-999
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139741868
- Cited by
- 1,060
- References
- 27
- FWCI
- 86.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.